PMID: 8590775Aug 1, 1995Paper

Biology of flt3 ligand and receptor

International Journal of Hematology
S D Lyman

Abstract

The flt3 ligand is a member of a small family of growth factors that stimulate the proliferation of hematopoietic cells; other members of this family include Steel factor (also known as mast cell growth factor, stem cell factor, and kit ligand) and colony stimulating factor 1. These proteins function by binding to and activating unique tyrosine kinase receptors. Expression of the flt3 receptor is primarily restricted among hematopoietic cells to the most primitive progenitor cells. The flt3 ligand is similar to Steel factor in that both proteins stimulate the proliferation of early progenitor or stem cells. Neither of these factors has much proliferative activity on its own, but each factor can synergize with a wide range of other colony stimulating factors and interleukins (ILs) to stimulate proliferation. One major difference between the two factors appears to be their effect on mast cells, which Steel factor stimulates but flt3 ligand does not. Although flt3 ligand and Steel factor each act on early hematopoietic cells, differences in their activities suggest that they are not redundant and both are required for normal hematopoiesis. There are a number of clinical settings in which the flt3 ligand may potentially prove quite...Continue Reading

Citations

Oct 3, 1999·Pediatric Hematology and Oncology·E IshiiS Miyazaki
Feb 7, 2001·Journal of Virology·D R DrakeA E Lukacher
Apr 16, 2003·British Journal of Haematology·Simone C C HartongGerard Wagemaker
Jun 15, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Zhuo ZhangHui Wang
Jan 18, 2006·Stem Cells·Bertrand W ParcellsKathleen M Sakamoto
Nov 14, 2015·Journal of Cellular Biochemistry·Rayapadi G SwethaAnand Anbarasu
Jul 4, 1998·The Journal of Biological Chemistry·T J GraddisJ T McGrew
Nov 26, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A AiutiM Tripodi
Aug 6, 1998·Journal of Biomedical Science·C H Chen, T C Wu
Apr 4, 2006·American Journal of Veterinary Research·Regina ZavodovskayaCheryl A London
Jun 7, 2008·Hematology·Michela PalmisanoGiovanni Martinelli
Aug 5, 2015·Journal of Clinical Medicine·Elzbieta Gocek, George P Studzinski
Oct 14, 2016·Journal of Cellular Biochemistry·Akbar AliAbdul Rauf Shakoori
Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Apr 2, 2002·Journal of Immunotherapy·Bruce J AverbookCharles Maliszewski
Aug 20, 2002·Journal of Hematotherapy & Stem Cell Research·Joud H HaidarRose Daher
Jun 4, 2002·Current Opinion in Hematology·D Gary Gilliland, James D Griffin
Oct 29, 2002·Leukemia & Lymphoma·Hitoshi Kiyoi, Tomoki Naoe
Sep 9, 2005·International Journal of Hematology·Hitoshi KiyoiKazutaka Ozekia
Oct 26, 2007·Cancer Chemotherapy and Pharmacology·Lars MöllgårdSören Lehmann
Dec 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne L AstierNir Hacohen
Aug 23, 2012·Expert Opinion on Therapeutic Patents·Giorgio CozzaStefano Moro
Jan 1, 2011·Cancers·Elzbieta Gocek, Ewa Marcinkowska
Jan 19, 2000·Leukemia·A SolanillaJ Ripoche
Aug 6, 2003·British Journal of Haematology·Panagiotis D KottaridisDavid C Linch
Nov 1, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robert K StrotherVladimir P Badovinac
Jan 17, 2020·The FEBS Journal·Panagiota S GeorgouliaRan Friedman
Nov 3, 2005·Leukemia & Lymphoma·Rui Zheng, Donald Small
Jun 29, 2005·British Journal of Haematology·Giovanni F TorelliRobin Foa
Jul 11, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Jung-Min KohEui Kyun Park
Oct 9, 2014·Frontiers in Oncology·Colleen E Annesley, Patrick Brown
Nov 21, 2020·Journal of Hematology & Oncology·Melat T Gebru, Hong-Gang Wang
Feb 24, 1999·Experimental Hematology·C LiuD Small

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.